Boston Trust Walden Corp Sells 77,917 Shares of The Cooper Companies, Inc. $COO

Boston Trust Walden Corp cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 6.3% during the first quarter, Holdings Channel.com reports. The firm owned 1,159,562 shares of the medical device company’s stock after selling 77,917 shares during the quarter. Boston Trust Walden Corp’s holdings in Cooper Companies were worth $82,909,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in COO. Wellington Management Group LLP boosted its holdings in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Generation Investment Management LLP bought a new position in shares of Cooper Companies in the 4th quarter valued at about $233,539,000. Diamond Hill Capital Management Inc. increased its position in shares of Cooper Companies by 479.6% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after acquiring an additional 2,720,594 shares during the last quarter. JANA Partners Management LP bought a new stake in Cooper Companies during the third quarter worth about $166,917,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Wells Fargo & Company restated a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Finally, Robert W. Baird lowered their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Stock Performance

COO opened at $74.20 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The business has a 50 day moving average of $64.36 and a 200-day moving average of $73.37. The stock has a market cap of $14.47 billion, a price-to-earnings ratio of 62.88, a PEG ratio of 1.88 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the firm earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.